Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

. 2018 Feb 08 ; 9 (1) : 556. [epub] 20180208

Jazyk angličtina Země Anglie, Velká Británie Médium electronic

Typ dokumentu časopisecké články, metaanalýza, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid29422604

Grantová podpora
R01 CA102765 NCI NIH HHS - United States
P30 CA016087 NCI NIH HHS - United States
MR/N003284/1 Medical Research Council - United Kingdom
P30 ES000260 NIEHS NIH HHS - United States
HHSN261200800001C NCI NIH HHS - United States
HHSN268201600003C NHLBI NIH HHS - United States
R01 HL026490 NHLBI NIH HHS - United States
R01 CA154823 NCI NIH HHS - United States
U58 DP003862 NCCDPHP CDC HHS - United States
U01 CA210171 NCI NIH HHS - United States
U10 CA037429 NCI NIH HHS - United States
HHSN268201600002C NHLBI NIH HHS - United States
U01 CA167462 NCI NIH HHS - United States
P01 CA087969 NCI NIH HHS - United States
P50 CA062924 NCI NIH HHS - United States
HHSN268201600018C NHLBI NIH HHS - United States
UL1 TR001863 NCATS NIH HHS - United States
R01 HL043851 NHLBI NIH HHS - United States
U24 CA074783 NCI NIH HHS - United States
UG1 CA189974 NCI NIH HHS - United States
R01 HL034595 NHLBI NIH HHS - United States
HHSN268201100011I NHLBI NIH HHS - United States
HHSN268201100011C NHLBI NIH HHS - United States
UM1 CA182934 NCI NIH HHS - United States
R01 CA098870 NCI NIH HHS - United States
P30 CA008748 NCI NIH HHS - United States
U01 CA167551 NCI NIH HHS - United States
P50 CA102701 NCI NIH HHS - United States
G0401527 Medical Research Council - United Kingdom
R01 CA098661 NCI NIH HHS - United States
UM1 CA186107 NCI NIH HHS - United States
HHSN268201600004C NHLBI NIH HHS - United States
G1000143 Medical Research Council - United Kingdom
R01 CA047988 NCI NIH HHS - United States
R01 CA109767 NCI NIH HHS - United States
HHSN268201600001C NHLBI NIH HHS - United States
R01 HL080467 NHLBI NIH HHS - United States
14136 Cancer Research UK - United Kingdom
UM1 CA167552 NCI NIH HHS - United States
U01 CA074783 NCI NIH HHS - United States
R01 CA049449 NCI NIH HHS - United States
R01 CA040360 NCI NIH HHS - United States
001 World Health Organization - International
R01 CA097075 NCI NIH HHS - United States
RC1 HL099355 NHLBI NIH HHS - United States
UM1 CA182883 NCI NIH HHS - United States
UM1 CA167462 NCI NIH HHS - United States
R01 CA097193 NCI NIH HHS - United States
R01 CA034944 NCI NIH HHS - United States
HHSN261200800001E NCI NIH HHS - United States
R03 CA123546 NCI NIH HHS - United States

Odkazy

PubMed 29422604
PubMed Central PMC5805680
DOI 10.1038/s41467-018-02942-5
PII: 10.1038/s41467-018-02942-5
Knihovny.cz E-zdroje

In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Here, we find significant evidence of a novel association at rs78417682 (7p12/TNS3, P = 4.35 × 10-8). Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10-14), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10-10), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10-8), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10-8). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA. Expression quantitative trait locus analysis in three independent pancreatic data sets provides molecular support of NOC2L as a pancreatic cancer susceptibility gene.

1st Department of Medicine University of Szeged 6725 Szeged Hungary

ARC NET Centre for Applied Research on Cancer University and Hospital Trust of Verona 37134 Verona Italy

Boston VA Healthcare System Boston MA 02132 USA

Cancer Care Ontario University of Toronto Toronto Ontario M5G 2L7 Canada

Cancer Epidemiology and Intelligence Division Cancer Council Victoria Melbourne VIC 3004 Australia

Cancer Epidemiology Program University of Hawaii Cancer Center Honolulu HI 96813 USA

Cancer Genomics Research Laboratory National Cancer Institute Division of Cancer Epidemiology and Genetics Leidos Biomedical Research Inc Frederick National Laboratory for Cancer Research Frederick MD 21702 USA

Centre de Recherche en Épidémiologie et Santé des Populations Facultés de Medicine Université Paris Saclay UPS UVSQ Gustave Roussy 94800 Villejuif France

Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health The University of Melbourne Parkville VIC 3010 Australia

CIBER Epidemiología y Salud Pública 08003 Barcelona Spain

CIBERONC 28029 Madrid Spain

Dalla Lana School of Public Health University of Toronto Toronto Ontario M5T 3M7 Canada

Departament de Ciències Experimentals i de la Salut Universitat Pompeu Fabra 08002 Barcelona Spain

Department for Determinants of Chronic Diseases 3720 BA Bilthoven The Netherlands

Department of Basic Medical Sciences Laboratory of Biology Medical School National and Kapodistrian University of Athens 106 79 Athens Greece

Department of Biology University of Pisa 56126 Pisa Italy

Department of Biostatistics Harvard School of Public Health Boston MA 02115 USA

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute 65653 Brno Czech Republic

Department of Chronic Disease Epidemiology Yale School of Public Health New Haven CT 06520 USA

Department of Computational Biology St Jude Children's Research Hospital Memphis TN 38105 USA

Department of Digestive Tract Diseases Medical University of Łodz 90 647 Łodz Poland

Department of Environmental Medicine New York University School of Medicine New York NY 10016 USA

Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York NY 10065 USA

Department of Epidemiology and Biostatistics School of Public Health Imperial College London London SW7 2AZ UK

Department of Epidemiology and Biostatistics University of California San Francisco San Francisco CA 94158 USA

Department of Epidemiology and Environmental Health University at Buffalo Buffalo NY 14214 USA

Department of Epidemiology and Preventive Medicine Monash University Melbourne VIC 3004 Australia

Department of Epidemiology and Public Health Faculty of Medicine University of Ostrava 701 03 Ostrava Czech Republic

Department of Epidemiology Harvard School of Public Health Boston MA 02115 USA

Department of Epidemiology Harvard T H Chan School of Public Health Boston MA 02115 USA

Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD 21205 USA

Department of Epidemiology University of Texas MD Anderson Cancer Center Houston TX 77230 USA

Department of Epidemiology University of Washington Seattle WA 98195 USA

Department of Gastroenterology and Hepatology University Medical Centre 3584 CX Utrecht The Netherlands

Department of Gastroenterology Lithuanian University of Health Sciences 44307 Kaunas Lithuania

Department of Gastrointestinal Medical Oncology University of Texas MD Anderson Cancer Center Houston TX 77030 USA

Department of General Surgery University Hospital Heidelberg 69120 Heidelberg Germany

Department of General Surgery University of Heidelburg Heidelberg Germany

Department of General Visceral and Thoracic Surgery University Hamburg Eppendorf 20246 Hamburg Germany

Department of Health Sciences Research Mayo Clinic College of Medicine Rochester MN 55905 USA

Department of Hematology Institute of Hematology and Transfusion Medicine 02 776 Warsaw Poland

Department of Medical Oncology Dana Farber Cancer Institute Boston MA 02215 USA

Department of Medicine Georgetown University Washington 20057 USA

Department of Medicine Memorial Sloan Kettering Cancer Center New York NY 10065 USA

Department of Molecular Biology of Cancer Institute of Experimental Medicine Academy of Sciences of the Czech Republic 142 20 Prague 4 Czech Republic

Department of Obstetrics and Gynecology New York University School of Medicine New York NY 10016 USA

Department of Oncology Faculty of Medicine and Dentistry Palacky University Olomouc and University Hospital 775 20 Olomouc Czech Republic

Department of Oncology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins School of Medicine Baltimore MD 21231 USA

Department of Pathology Academic Medical Center University of Amsterdam 1007 MB Amsterdam The Netherlands

Department of Pathology Sol Goldman Pancreatic Cancer Research Center Johns Hopkins School of Medicine Baltimore MD 21287 USA

Department of Population Health New York University School of Medicine New York NY 10016 USA

Department of Preventive Medicine Keck School of Medicine University of Southern California Los Angeles CA 90032 USA

Department of Public Health Solutions National Institute for Health and Welfare 00271 Helsinki Finland

Department of Radiation Oncology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins School of Medicine Baltimore MD 21231 USA

Department of Social and Preventive Medicine Faculty of Medicine University of Malaya 50603 Kuala Lumpur Malaysia

Department of Surgery Oncology and Gastroenterology University of Padua 35124 Padua Italy

Department of Surgical and Perioperative Sciences Umeå University 901 85 Umeå Sweden

Department of Translational Research and The New Technologies in Medicine and Surgery University of Pisa 56126 Pisa Italy

Digestive and Liver Disease Unit 'Sapienza' University of Rome 00185 Rome Italy

Division of Aging Brigham and Women's Hospital Boston MA 02115 USA

Division of Cancer Control and Population Sciences National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Division of Cancer Epidemiology German Cancer Research Center 69120 Heidelberg Germany

Division of Clinical Epidemiology and Aging Research German Cancer Research Center 69120 Heidelberg Germany

Division of Epidemiology Department of Medicine Vanderbilt Epidemiology Center Vanderbilt Ingram Cancer Center Vanderbilt University School of Medicine Nashville TN 37232 USA

Division of Gastroenterology and Research Laboratory IRCCS Scientific Institute and Regional General Hospital Casa Sollievo della Sofferenza 71013 San Giovanni Rotondo FG Italy

Division of Preventive Medicine Brigham and Women's Hospital Boston MA 02215 USA

Division of Preventive Oncology German Cancer Research Center 69120 Heidelberg Germany

Division of Public Health Sciences Fred Hutchinson Cancer Research Center Seattle WA 98109 USA

Division of Research Kaiser Permanente Northern California Oakland CA 94612 USA

Epidemiology Research Program American Cancer Society Atlanta GA 30303 USA

Epithelial Carcinogenesis Group Spanish National Cancer Research Centre CNIO 28029 Madrid Spain

Faculty of Medicine University of Olomouc 771 47 Olomouc Czech Republic

Gastroenterology and Gastrointestinal Endoscopy Unit Vita Salute San Raffaele University IRCCS San Raffaele Scientific Institute 20132 Milan Italy

Genetic and Molecular Epidemiology Group Spanish National Cancer Research Center 28029 Madrid Spain

Genomic Epidemiology Group German Cancer Research Center 69120 Heidelberg Germany

Glickman Urological and Kidney Institute Cleveland Clinic Cleveland OH 44195 USA

Hospital del Mar Institute of Medical Research Universitat Autònoma de Barcelona 08003 Barcelona Spain

Institute of Public Health and Preventive Medicine Charles University 2nd Faculty of Medicine 150 06 Prague 5 Czech Republic

International Agency for Research on Cancer 69372 Lyon France

ISGlobal Centre for Research in Environmental Epidemiology 08003 Barcelona Spain

Laboratory for Pharmacogenomics Biomedical Center Faculty of Medicine in Pilsen Charles University 323 00 Pilsen Czech Republic

Laboratory of Translational Genomics Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Lunenfeld Tanenbaum Research Institute of Mount Sinai Hospital Toronto Ontario M5G 1×5 Canada

National Center for Tumor Diseases 69120 Heidelberg Germany

Oncology Department ASL1 Massa Carrara Carrara 54033 Italy

Pancreas Unit Department of Digestive Diseases and Internal Medicine Sant'Orsola Malpighi Hospital 40138 Bologna Italy

Perlmutter Cancer Center New York University School of Medicine New York NY 10016 USA

Population Health Department QIMR Berghofer Medical Research Institute Brisbane 4029 Australia

School of Clinical Medicine University of Cambridge Cambridge CB2 0SP UK

SWOG Statistical Center Fred Hutchinson Cancer Research Center Seattle WA 98109 USA

Unit of Nutrition and Cancer Cancer Epidemiology Research Program Bellvitge Biomedical Research Institute Barcelona 08908 Spain

Universitat Pompeu Fabra 08002 Barcelona Spain

Yale Cancer Center New Haven CT 06510 USA

Zobrazit více v PubMed

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. Ca. Cancer J. Clin. 2016;66:7–30. doi: 10.3322/caac.21332. PubMed DOI

Ferlay, J. et al. http://globocan.iarc.fr (IARC, Lyon, France, 2013).

Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2014. Ann. Oncol. 2014;25:1650–1656. doi: 10.1093/annonc/mdu138. PubMed DOI

Rahib L, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. doi: 10.1158/0008-5472.CAN-14-0155. PubMed DOI

Goldstein AM, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006;66:9818–9828. doi: 10.1158/0008-5472.CAN-06-0494. PubMed DOI

Jones S, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 2009;324:217. doi: 10.1126/science.1171202. PubMed DOI PMC

Kastrinos F, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009;302:1790–1795. doi: 10.1001/jama.2009.1529. PubMed DOI PMC

Lowenfels AB, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl Cancer Inst. 1997;89:442–446. doi: 10.1093/jnci/89.6.442. PubMed DOI

Roberts NJ, et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2012;2:41–46. doi: 10.1158/2159-8290.CD-11-0194. PubMed DOI PMC

Goggins M, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 1996;56:5360–5364. PubMed

Giardiello FM, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. 1987;316:1511–1514. doi: 10.1056/NEJM198706113162404. PubMed DOI

Amundadottir L, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet. 2009;41:986–990. doi: 10.1038/ng.429. PubMed DOI PMC

Petersen GM, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet. 2010;42:224–228. doi: 10.1038/ng.522. PubMed DOI PMC

Wolpin BM, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat. Genet. 2014;46:994–1000. doi: 10.1038/ng.3052. PubMed DOI PMC

Zhang, M. et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget, 10.18632/oncotarget.11041 (2016). PubMed PMC

Childs EJ, et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat. Genet. 2015;47:911–916. doi: 10.1038/ng.3341. PubMed DOI PMC

Campa, D. et al. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int. J. Cancer10.1002/ijc.29590 (2015). PubMed PMC

Wang Z, et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum. Mol. Genet. 2014;23:6616–6633. doi: 10.1093/hmg/ddu363. PubMed DOI PMC

Wu C, et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat. Genet. 2012;44:62–66. doi: 10.1038/ng.1020. PubMed DOI

Low SK, et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS ONE. 2010;5:e11824. doi: 10.1371/journal.pone.0011824. PubMed DOI PMC

Campa D, et al. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol. Biomark. Prev. 2013;22:320–323. doi: 10.1158/1055-9965.EPI-12-1182. PubMed DOI

Consortium TGP. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–1073. doi: 10.1038/nature09534. PubMed DOI PMC

Campa D, et al. Dig. Liver Dis. 2013. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium; pp. 95–99. PubMed

Hublitz P, et al. NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev. 2005;19:2912–2924. doi: 10.1101/gad.351205. PubMed DOI PMC

Wu L, Ma CA, Zhao Y, Jain A. Aurora B interacts with NIR-p53, leading to p53 phosphorylation in its DNA-binding domain and subsequent functional suppression. J. Biol. Chem. 2011;286:2236–2244. doi: 10.1074/jbc.M110.174755. PubMed DOI PMC

Heyne K, et al. NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle. Nucleic Acids Res. 2010;38:3159–3171. doi: 10.1093/nar/gkq016. PubMed DOI PMC

Baraille F, et al. Glucose tolerance is improved in mice invalidated for the nuclear receptor HNF-4gamma: a critical role for enteroendocrine cell lineage. Diabetes. 2015;64:2744–2756. doi: 10.2337/db14-0993. PubMed DOI

Kottgen A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat. Genet. 2013;45:145–154. doi: 10.1038/ng.2500. PubMed DOI PMC

Mayers JR, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat. Med. 2014;20:1193–1198. doi: 10.1038/nm.3686. PubMed DOI PMC

Speliotes EK, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 2010;42:937–948. doi: 10.1038/ng.686. PubMed DOI PMC

Berndt SI, et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 2013;45:501–512. doi: 10.1038/ng.2606. PubMed DOI PMC

Michailidou K, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 2013;45:353–361. doi: 10.1038/ng.2563. PubMed DOI PMC

Haumaitre C, et al. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc. Natl Acad. Sci. USA. 2005;102:1490–1495. doi: 10.1073/pnas.0405776102. PubMed DOI PMC

Solar M, et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev. Cell. 2009;17:849–860. doi: 10.1016/j.devcel.2009.11.003. PubMed DOI

Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care. 2011;34:1878–1884. doi: 10.2337/dc11-0035. PubMed DOI PMC

Berndt SI, et al. Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum. Mol. Genet. 2011;20:3322–3329. doi: 10.1093/hmg/ddr213. PubMed DOI PMC

Painter JN, et al. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum. Mol. Genet. 2015;24:1478–1492. doi: 10.1093/hmg/ddu552. PubMed DOI PMC

Kristiansen W, et al. Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor. Hum. Mol. Genet. 2015;24:4138–4146. doi: 10.1093/hmg/ddv129. PubMed DOI

Odom DT, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004;303:1378–1381. doi: 10.1126/science.1089769. PubMed DOI PMC

Molero X, et al. Gene expression dynamics after murine pancreatitis unveils novel roles for Hnf1alpha in acinar cell homeostasis. Gut. 2012;61:1187–1196. doi: 10.1136/gutjnl-2011-300360. PubMed DOI

El-Khairi R, Vallier L. The role of hepatocyte nuclear factor 1beta in disease and development. Diabetes Obes. Metab. 2016;18 Suppl 1:23–32. doi: 10.1111/dom.12715. PubMed DOI

Ktistaki E, Talianidis I. Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science. 1997;277:109–112. doi: 10.1126/science.277.5322.109. PubMed DOI

Boj SF, Parrizas M, Maestro MA, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl Acad. Sci. USA. 2001;98:14481–14486. doi: 10.1073/pnas.241349398. PubMed DOI PMC

Hoskins JW, et al. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Carcinogenesis. 2014;35:2670–2678. doi: 10.1093/carcin/bgu193. PubMed DOI PMC

Luo Z, et al. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer. PLoS ONE. 2015;10:e0121082. doi: 10.1371/journal.pone.0121082. PubMed DOI PMC

Stolzenberg-Solomon RZ, Amundadottir LT. Epidemiology and inherited predisposition for sporadic pancreatic adenocarcinoma. Hematol. Oncol. Clin. North Am. 2015;29:619–640. doi: 10.1016/j.hoc.2015.04.009. PubMed DOI PMC

Locke AE, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206. doi: 10.1038/nature14177. PubMed DOI PMC

Replication DIG, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 2014;46:234–244. doi: 10.1038/ng.2897. PubMed DOI PMC

Park HS, Kwon HY, Lee YL, Chey WY, Park HJ. Role of GRPergic neurons in secretin-evoked exocrine secretion in isolated rat pancreas. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278:G557–G562. doi: 10.1152/ajpgi.2000.278.4.G557. PubMed DOI

Liu JZ, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 2015;47:979–986. doi: 10.1038/ng.3359. PubMed DOI PMC

Blangy A. Tensins are versatile regulators of Rho GTPase signalling and cell adhesion. Biol. Cell. 2017;109:115–126. doi: 10.1111/boc.201600053. PubMed DOI

Qian X, et al. The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell. 2009;16:246–258. doi: 10.1016/j.ccr.2009.07.031. PubMed DOI PMC

Hirano T. Condensin-based chromosome organization from bacteria to vertebrates. Cell. 2016;164:847–857. doi: 10.1016/j.cell.2016.01.033. PubMed DOI

Rachidi SM, Qin T, Sun S, Zheng WJ, Li Z. Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker. PLoS ONE. 2013;8:e57911. doi: 10.1371/journal.pone.0057911. PubMed DOI PMC

Golson ML, Kaestner KH. Fox transcription factors: from development to disease. Development. 2016;143:4558–4570. doi: 10.1242/dev.112672. PubMed DOI PMC

Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 2012;40:W478–W483. doi: 10.1093/nar/gks402. PubMed DOI PMC

Pers TH, et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 2015;6:5890. doi: 10.1038/ncomms6890. PubMed DOI PMC

Zhang, M. et al. Characterizing cis-regulatory variation in the transcriptome of histologically normal and tumor-derived pancreatic tissues Gut 0:1–13 (2017). PubMed PMC

Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat. Rev. Cancer. 2010;10:65–76. doi: 10.1038/nrc2681. PubMed DOI PMC

Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529. doi: 10.1371/journal.pgen.1000529. PubMed DOI PMC

Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 2007;39:906–913. doi: 10.1038/ng2088. PubMed DOI

de Bakker PI, et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 2008;17:R122–R128. doi: 10.1093/hmg/ddn288. PubMed DOI PMC

Luna A, Nicodemus KK. snp.plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package. Bioinformatics. 2007;23:774–776. doi: 10.1093/bioinformatics/btl657. PubMed DOI

Consortium G. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–660. doi: 10.1126/science.1262110. PubMed DOI PMC

Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. doi: 10.1186/1471-2105-12-323. PubMed DOI PMC

Wang K, et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 2010;38:e178. doi: 10.1093/nar/gkq622. PubMed DOI PMC

Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 2010;11:499–511. doi: 10.1038/nrg2796. PubMed DOI

Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012;28:1353–1358. doi: 10.1093/bioinformatics/bts163. PubMed DOI PMC

Vorontsov IE, et al. PERFECTOS-APE - predicting regulatory functional effect of SNPs by approximate P-value estimation. Bioinformatics. 2015;1:102–108.

Thomas-Chollier M, et al. Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs. Nat. Protoc. 2011;6:1860–1869. doi: 10.1038/nprot.2011.409. PubMed DOI

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Large-Scale Alternative Polyadenylation-Wide Association Studies to Identify Putative Cancer Susceptibility Genes

. 2024 Aug 15 ; 84 (16) : 2707-2719.

Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women

. 2022 Oct 27 ; 12 (1) : 18100. [epub] 20221027

Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium

. 2022 May 04 ; 31 (5) : 942-948.

Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk

. 2021 ; 11 () : 771312. [epub] 20211203

Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies

. 2021 Oct 04 ; 114 (4) : 1408-1417.

Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk

. 2021 ; 12 () : 693933. [epub] 20210830

Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer

. 2021 Jun ; 5 (3) : . [epub] 20210419

Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival

. 2021 Apr 07 ; 11 (1) : 7570. [epub] 20210407

Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer

. 2019 Jun 01 ; 111 (6) : 557-567.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...